U.S. Markets closed

PharmaVOICE Magazine Announces the 2013 PharmaVOICE 100

TITUSVILLE, NJ--(Marketwired - Aug 1, 2013) - Established nine years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry.

These individuals illustrate what it means to think bigger, do more, and lead with passion and integrity. Based on their profiles, it is no surprise that you, our readers, have identified this year's honorees as some of the most inspiring, motivating, and outstanding leaders in the life-sciences industry.

The distinguished honorees are nominated by thousands of PharmaVOICE readers throughout the year and are selected based on well-crafted and comprehensive essays describing how they have inspired or motivated their colleagues, peers, and even competitors; have affected positive changes in their own organizations; as well as other factors, such as community and philanthropic activities.

The PharmaVOICE 100 honorees represent a broad cross-section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, marketing, technology, and many others.

"This special issue, now in its ninth year, has become one of the most-anticipated publications of the year, and it is our extreme pleasure to once again showcase the women and men who are providing exemplary leadership, changing the status quo, fostering innovation along the entire continuum, and building relationships to position the industry in the best way possible to serve the ultimate stakeholders: patients," said Taren Grom, Editor and Cofounder of PharmaVOICE.

View the 2013 list at: http://www.pharmavoice.com/content/digitaledition.html?pg=8

About PharmaVOICE:
PharmaVOICE is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE, with the largest distribution in its market sector, is delivered to more than 34,000 BPA-qualified subscribers, which include executives from pharmaceutical manufacturing, biotechnology, drug discovery, research & development, contract research, drug delivery, and device/diagnostic companies. The publication also targets decision makers at healthcare advertising, marketing, medical education, public relations, information technology, contract sales, traditional and nontraditional media, and other service support companies and organizations. The publication also reaches more than 100,000 users with its digital edition, which contains original exclusive bonus content.

PharmaVOICE's unique horizontal editorial approach cuts across industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics.